Anlon Healthcare Current Share Price | Anlon Healthcare Stock Screener
AHCL
Pharmaceuticals
Anlon Healthcare Current Stock Price Today
Live Share Price NSE
₹14.53
▼
-0.10 (-0.68%)
Live Share Price BSE
₹14.52
▼
-0.08 (-0.55%)
As of August 19, 2026, the live Anlon Healthcare share price (NSE: AHCL) is ₹14.53 on NSE and ₹14.52 on BSE, down 0.68% from the previous close, with shares trading between ₹14.38 and ₹14.70 in today's trading session, and a 52-week range of ₹13.11–₹154.70.
Analyse Anlon Healthcare stock price data download and track historical price performance.
Use the Anlon Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Anlon Healthcare Market Cap
₹777.61 Cr.
AHCL P/E Ratio (TTM)
22.69
Anlon Healthcare P/B Ratio
3.35
EPS (TTM)
₹5.93
Dividend Yield
-
Debt to Equity
1.46
AHCL 52 Week High
₹154.70
Anlon Healthcare 52 Week Low
₹13.11
Operating Margin
30.00%
Profit Margin
21.57%
AHCL Revenue (TTM)
₹51.00
EBITDA
₹15.00
Net Income
₹11.00
Total Assets
₹317.00
Total Equity
₹210.00
Anlon Healthcare Current Share Price Chart
Track the current Anlon Healthcare share price and stock price with an interactive chart. Analyse AHCL price trends, trading volume, historical performance, and volatility across different timeframes — the complete Anlon Healthcare stock quote in one place.
Anlon Healthcare Company Profile - Fundamental Screener
Screen Anlon Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AHCL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0Y8W01025
Anlon Healthcare Balance Sheet Screener
Screen AHCL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 317 | 181 | 128 | 112 | 85 | 71 |
| Current Assets | 260 | 159 | 101 | 86 | 58 | 40 |
| Fixed Assets | 40 | 23 | 27 | 26 | 27 | 29 |
| Liabilities | ||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 7 | 41 | 57 | 61 | 55 | 38 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 210 | 80 | 21 | 7 | 2 | 2 |
| Share Capital | 53 | 40 | 16 | 12 | 12 | 12 |
| Reserves & Surplus | 157 | 41 | 5 | -5 | -10 | -10 |
Anlon Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Anlon Healthcare income statement and profit fundamentals.
Analyze AHCL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Anlon Healthcare share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec |
|---|---|---|---|---|---|---|
| Revenue | 51 | 88 | 49 | 33 | 52 | 36 |
| Expenses | 36 | 72 | 32 | 27 | 39 | 23 |
| EBITDA | 15 | 16 | 17 | 6 | 14 | 13 |
| Operating Profit % | 30.00% | 18.00% | 35.00% | 19.00% | 26.00% | 35.00% |
| Depreciation | 0 | 1 | 1 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 14 | 14 | 16 | 5 | 12 | 11 |
| Tax | 3 | 5 | -1 | 2 | 3 | 6 |
| Net Profit | 11 | 8 | 17 | 4 | 9 | 5 |
| EPS | 2.33 | 0.16 | 5.15 | 0.89 | 1.75 | 1.13 |
Anlon Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen AHCL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -23 | -3 | -3 | -2 | -15 |
| Investing Activities | 3 | -3 | 0 | 0 | -3 |
| Financing Activities | 19 | 8 | 2 | 3 | 16 |
| Net Cash Flow | -1 | 2 | -1 | 1 | -2 |
Anlon Healthcare Shareholding Pattern Screener
See Anlon Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Anlon Healthcare promoter holding and ownership changes for AHCL on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Apr | 2025-Jun | 2025-Aug | 2025-Sept | 2025-Dec | 2024-Oct |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.68% | 52.68% | 70.26% | 52.68% | 70.26% | 52.68% | 52.68% | 70.26% |
| FII Holding | 0.32% | 1.67% | 0.00% | 14.42% | 0.00% | 0.00% | 0.23% | 0.00% |
| DII Holding | 4.60% | 1.22% | 0.00% | 4.35% | 0.00% | 2.83% | 4.49% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.38% | 26.19% | 0.00% | 14.64% | 0.00% | 20.73% | 23.58% | 0.00% |
| Other Holding | 18.02% | 18.24% | 29.74% | 13.92% | 29.74% | 23.75% | 19.02% | 29.74% |
| Shareholder Count | 12,484 | 34,671 | 131 | 9,125 | 135 | 9,126 | 11,412 | 109 |
Anlon Healthcare Share Dividend Screener - Share Yield Analysis
Check Anlon Healthcare dividend history with payout and yield data.
View Anlon Healthcare dividend details including ex-dates and amounts for AHCL stock.
Anlon Healthcare Stock Index Membership
See which indices include Anlon Healthcare stock.
Check AHCL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Anlon Healthcare Market Events Screener - Corporate Actions
Get Anlon Healthcare corporate actions including splits, bonuses, and buybacks.
Check Anlon Healthcare stock events that may affect AHCL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-30 | 2026-07-30 | Quarterly Result Announcement | NA | 5.86% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 2.59% |
| 2026-04-24 | 2026-03-06 | Split | 2:10 | 0.00% |
| 2026-04-24 | 2026-04-24 | Bonus | 1:1 | 18.26% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 4.04% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 2.44% |
Anlon Healthcare Competitors Screener - Peer Comparison
Screen AHCL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,899 | 37.28 | 61,674 | 12.69% | 11,565 | 33.60 |
| Divis Laboratories | 227,984 | 77.10 | 11,067 | 13.95% | 2,568 | 74.07 |
| Torrent Pharmaceuticals | 189,081 | 86.36 | 13,886 | 20.34% | 2,138 | 54.91 |
| Cipla | 115,611 | 34.42 | 29,045 | 2.24% | 3,870 | 44.38 |
| Zydus Life Science | 112,255 | 24.59 | 27,658 | 17.64% | 5,026 | 46.32 |
| Lupin | 102,054 | 18.61 | 29,039 | 26.75% | 5,356 | 32.17 |
| Dr Reddys Laboratories | 98,391 | 31.25 | 35,059 | 3.90% | 4,158 | 43.27 |
| Mankind Pharma | 98,293 | 47.94 | 14,636 | 14.85% | 1,938 | 38.61 |
| Laurus Labs | 97,930 | 89.15 | 6,868 | 22.01% | 890 | 64.93 |
| Aurobindo Pharma | 94,650 | 25.43 | 34,145 | 5.56% | 3,503 | 59.26 |
Anlon Healthcare Company Announcements - News Screener
Screen AHCL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-15 | Reg. 34 (1) Annual Report. | - |
| 2026-08-15 | Notice Of 13Th Annual General Meeting Of Anlon Healthcare Limited | - |
| 2026-08-15 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-14 | Corporate Action - Fixes Book Closure For Annual General Meeting | - |
| 2026-08-14 | Corporate Action Record Date Fixed For Annual General Meeting | - |
| 2026-08-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday August 13 2026 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-12 | Board Meeting Intimation for Rescheduled/Postponement Of Meeting | - |
| 2026-08-09 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |
| 2026-08-06 | Closure of Trading Window | - |
| 2026-08-06 | Board Meeting Intimation for Approve Notice Of 13Th Annual General Meeting Of The Company | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-30 | Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-30 | Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2026 | - |